Acarix Q2: Steps In the Right Direction, Gross Margins Remains High - Redeye
Redeye leaves its comments on Acarix following the announcement of its Q2 report. Overall, we see promising steps forward in the US, and the company is laying ground for a growth journey in the coming years.
ANNONS
Redeye leaves its comments on Acarix following the announcement of its Q2 report. Overall, we see promising steps forward in the US, and the company is laying ground for a growth journey in the coming years.